naltrexone 380 MG Injection

RxCUI: 637213
RxNorm name: naltrexone 380 MG Injection
Display name: naltrexone 380 MG Injection
Full name: naltrexone 380 MG Injection
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
VIVITROL	NALTREXONE	Alkermes, Inc.	cd11c435-b0f0-4bb9-ae78-60f101f3703f	2026-05-31	Warnings, Adverse reactions	Exact identifier rxcui: 637213
Naltrexone	NALTREXONE	Amneal Pharmaceuticals NY LLC	6de5637f-d527-4228-af1a-3aae71155cb5	2026-01-30	Warnings, Adverse reactions	Exact identifier rxcui: 637213

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
cd11c435-b0f0-4bb9-ae78-60f101f3703f	naltrexone 380 MG Injection [PSN] · naltrexone 380 MG Injection [SCD]	2	38	These highlights do not include all the information needed to use VIVITROL ® safely and effectively. See full prescribing information for VIVITROL. VIVITROL (naltrexone for extended-release injectable suspension), for intramuscular use Initial U.S. Approval: 1984	20251223
6de5637f-d527-4228-af1a-3aae71155cb5	naltrexone 380 MG Injection [PSN] · naltrexone 380 MG Injection [SCD]	2	1	These highlights do not include all the information needed to use naltrexone for extended-release injectable suspension safely and effectively. See full prescribing information for naltrexone for extended-release injectable suspension. Naltrexone for Extended-Release Injectable Suspension, for intramuscular use Initial U.S. Approval: 1984	20260130